# Morepen Laboratories Limited (MOREPENLAB)

> MOREPENLAB closed at ₹113.35 on 30 Oct 2026, trailing P/E 32.9, market cap ₹6,211 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Morepen Laboratories Limited (NSE: MOREPENLAB) closed at ₹113.35 on 30 Oct 2026, +135.7% over one year, against a 52-week range of ₹33.05 – ₹150.70.

In the quarter ended 30 Sept 2026 (consolidated, filed 27 Oct 2026) it reported revenue of ₹747 cr and net profit of ₹89 cr, a 11.9% net margin; revenue grew 81.4% and profit grew 155.0% year on year.

On four consecutive filed quarters its trailing P/E is 32.9; since 12 May 2025 its own P/E has ranged from 15.4 to 57.4 (median 24.4), and today's reading is higher than 82% of those 364 trading days.

From the balance sheet dated 30 Sept 2026: return on equity 25.8%, ROCE 30.8%, debt-to-equity 0.22, Piotroski F-score 5 of 9.

Against 27 Metals & Mining peers on NSE: Net margin higher than 56% of 27 sector peers; PBT margin higher than 52% of 27 sector peers; ROE higher than 67% of 27 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹113.35 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | -2.8% / +171.7% / +135.7% |
| 52-week low – high | ₹33.05 – ₹150.70 |
| Market capitalisation | ₹6,211 cr |
| Trailing P/E | 32.9 |
| Price / book | 4.50 |
| EV / EBITDA | 21.0 |
| Earnings yield | 3.0% |
| TTM EPS | ₹3.44 |
| TTM net profit | ₹189 cr |
| Quarter revenue | ₹747 cr |
| Quarter net profit | ₹89 cr |
| Net margin | 11.9% |
| Revenue growth (YoY) | +81.4% |
| Profit growth (YoY) | +155.0% |
| Return on equity | 25.8% |
| ROCE | 30.8% |
| Debt / equity | 0.22 |
| Current ratio | 1.98 |
| Free cash flow | ₹63 cr |
| Piotroski F-score | 5 / 9 |
| Average daily turnover (50 days) | ₹198.8 cr |

## Questions

### What is the P/E ratio of Morepen Laboratories Limited?

Morepen Laboratories Limited's trailing P/E is 32.9, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 12 May 2025 its P/E has ranged 15.4–57.4.

### What were Morepen Laboratories Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Morepen Laboratories Limited reported revenue of ₹747 cr and net profit of ₹89 cr (consolidated), filed with the exchange on 27 Oct 2026.

### What is Morepen Laboratories Limited's ROE?

Return on equity is 25.8% based on the balance sheet dated 30 Sept 2026.

### Does Morepen Laboratories Limited have debt?

Debt-to-equity is 0.22 on the balance sheet dated 30 Sept 2026.

### What is MOREPENLAB's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, MOREPENLAB traded between ₹33.05 and ₹150.70.

Sector: [Metals & Mining](https://trinetra.trade/sectors/metals-and-mining) · Page: https://trinetra.trade/fundamentals/MOREPENLAB

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._